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A  49  year-old  male  patient  recurred  to  the  emer-
ency  department  complaining  of  anorexia,  nausea,  cough
ith  mucopurulent  sputum  and  dyspnea  for  5  days.  He
ad  a  history  of  poorly  controlled  type  1  diabetes  mel-
itus  with  retinopathy,  neuropathy  and  renal  transplant
2  years  before)  for  end-stage  renal  failure.  The  patient
as  taking  immunosuppressive  therapy  with  prednisolone
20  mg/day),  tacrolimus  (2  mg/day)  and  mycophenolic  acid∗ Corresponding author.
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C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4720  mg/day).  A chest  X-ray,  blood  and  urine  tests  performed
ere  consistent  with  pneumococcal  pneumonia  and  diabetic
etoacidosis.  Therefore  he  was  admitted.  In  the  4th  day
fter  admission  the  patient  complained  of  heartburn  and
ysphagia.  An  upper  endoscopy  was  performed  and  revealed
xtensive  longitudinal  esophageal  deep  ulceration  and
hitish  plaque  in  the  medium  and  distal  esophagus  (Fig.  1).
he  histopathological  exam  of  the  esophageal  biopsy
howed  ulcerated  esophageal  mucosa  with  viral  inclusion-
ike  structures  in  the  epithelium,  suggestive  of  virus-induced
sophagitis  (Fig.  2).  Cytomegalovirus  (CMV)  immunohisto-
hemical  was  positive  and  conﬁrmed  the  diagnosis  of  CMV
sophagitis  (Fig.  3).  Ganciclovir  (5  mg/kg  every  12  h)  was
dministered  intravenously  for  14  days,  and  it  was  well-
olerated.  After  2  weeks  of  intense  therapy  and  immunosup-
ressive  regimen  adjustments,  dysphagia  improved  and  he
as  discharged  with  oral  valganciclovir  (900  mg  every  12  h).
CMV  is  a  major  cause  of  morbidity  and  a preventable
ause  of  mortality  in  immunocompromised  patients,  espe-
ially  transplant  recipients  and  those  infected  with  human
mmunodeﬁciency  virus.1--3 CMV  esophagitis  has  mostly  been
escribed  in  patients  with  acquired  immunodeﬁciency  syn-
rome,  however,  also  may  occur  as  a  complication  of
mmunosuppressive  therapy,  or  even  in  immunocompetent
atients.3,4 The  gastro-intestinal  tract  is  the  commonest
rgan  to  be  involved  in  CMV  infection  and  esophagitis  is  the
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Figure  1  (a  and  b)  Endoscopic  ﬁndings,  revealing  extensive  longitudinal  esophageal  deep  ulceration  and  whitish  plaque  in  the
medium and  distal  esophagus.
Figure  2  Esophagic  mucosa  with  ulceration  (a  --  HE  40×)  and  endo
(b --  HE  200×).
s
t
o
a
e
e
p
s
a
i
p
t
(
e
a
cFigure  3  Immunohistochemistry  with  positivity  for  CMV
(400×).
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vthelial  cell  with  nuclear  inclusion  suggestive  of  viral  infection
econd  most  common  gastrointestinal  manifestation,  next
o  colitis.2
Patients  with  CMV  esophagitis  present  with  odynophagia
r  dysphagia.  Symptoms  are  indistinguishable  from  those
ssociated  with  Candida  or  HSV  esophagitis.5 Usually,  the
ndoscopic  appearance  is  typiﬁed  by  large  shallow  ulcers,
ither  solitary  or  multiple,  located  in  the  middle  or  distal
art  of  the  esophagus.5 Histopathologic  examination  analy-
is  demonstrating  active  disease  and  immunohistochemistry
re  the  most  reliable  diagnostic  methods  in  cases  of  tissue-
nvasive  disease.3
Potent  antiviral  agents,  are  essential  in  the  treatment  of
atients  with  non-HIV  causes  of  immunosuppression,  such  as
ransplantation.  For  nonsevere  CMV  disease,  valganciclovir
900  mg  every  12  h)  or  intravenous  ganciclovir  (5  mg/kg
very  12  h)  are  recommended  as  ﬁrst-line  treatment  in
dults.  Conversion  from  intravenous  ganciclovir  to  valganci-
lovir  may  be  performed  without  interrupting  dosing.1 When
ptimal  drug  exposure  is  required,  such  in  severe  or  life-
hreatening  CMV  disease,  those  with  high  viral  load,  and
hose  with  questionable  gastrointestinal  absorption,  intra-
enous  ganciclovir  is  recommended.1,2 Dose  reduction  of
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mmunosuppressive  therapy  should  be  considered  in  cases  of
evere  CMV  disease,  in  nonresponding  patients,  in  patients
ith  high  viral  loads  or  leukopenia.1
CMV-associated  gastrointestinal  infections  are  generally
esolved  without  clinical  symptoms  in  immunocompe-
ent  patients,  but  the  infection  can  be  fatal  in  the
mmunocompromised.5 Early  recognition  of  this  clinical
ntity  is  of  vital  importance  to  implement  appropriate  ther-
py  and  avoid  potentially  fatal  complications.
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